JOSEPH V.
SWINTOSKY, Ph.D.
303 S. MAIN
STREET
NICHOLASVILLE,
KENTUCKY 40356
Email: coolmom1931@yahoo.com
Professional: Emeritus Dean and Professor of Pharmacy, College of Pharmacy, University of Kentucky, Lexington, KY. Retains professional office at the College of Pharmacy.
Personal: Born, December 14, 1921 in rural
Kewaunee, Wisconsin, near Green Bay.
Married to Dorothy (Zevnik) Swintosky.
Parents of 9 sons and 1 daughter.
Education: Public Schools, Kewaunee, Wisconsin.
Started pharmacy school education at the
University of Wisconsin-Madison, 1938
B.S., Pharmacy, University of Wisconsin,
1942.
Ph.D., Pharmacy, University of Wisconsin,
1948.
Employment:
1942
Started
graduate studies in pharmacy with annual stipend of $300 at the University of
Wisconsin (UW)
.
1945-48
Assumed
position during 1945-48 of Part-Time Instructor (Lecturer) in pharmaceutical
organic chemistry and pharmacy, while continuing graduate study at UW. Carried some responsibilities of Full-Time
Faculty when, during, and after WWII, faculty ranks were depleted.
1947-48
American
Foundation for Pharmaceutical Education (AFPE) Fellow.
1948-53
UW
Assistant Professor of Pharmacy and Pharmacognosy.
1953
Joined
Smith Kline & French Labs (SK&F) in R&D, in Philadelphia,
Pennsylvania, on July 1, 1953, after taking leave of absence from UW.
1953-66
Started
as Senior Scientist, and then in 1954 became R&D Group Leader for Tablets,
Capsules, and Powders. For various
prolonged periods during 1954-66 became Program Team Director for research
programs in a) Time Action Principle (oral sustained release product theory and
technology), b) Formulation Principle,
c) Prodrugs, and d) Drug Absorption Principle.
1960-66
Served
as Principal Research Pharmacist for several years, then as Section Head for
Pharmaceutical Research in R&D, SK&F.
Regarded as a pioneer and founder in fields of preformulation research,
biopharmaceutics, and clinical pharmacokinetics applied to drug product
development; and an authority on oral sustained and controlled release
methodology.
1967
Became
Dean and Professor, University of Kentucky (UK), College of Pharmacy, January
1, 1967 – June 30, 1987. Retired as
Dean at the age of 65.
1987
Professor
of Pharmacy, July 1, 1987.
1989-Present Emeritus Dean and Professor, UK College of
Pharmacy.
Professional
Organizations; served as a member for prolonged periods in the following:
Kentucky Pharmacists
Association
Bluegrass Pharmaceutical
Association
American Pharmaceutical
Association (APhA)
Academy of
Pharmaceutical Sciences (APS)
American Association of
Pharmaceutical Scientists (AAPS)
American Chemical
Society (ACS); also Lexington Chapter
American Association for
Advancement of Science (AAAS)
American Institute for
the History of Pharmacy
American Public Health
Association
Conference of Teachers,
American Association of Colleges of Pharmacy
Academy of General
Practice (APhA)
International
Pharmaceutical Federation (FIP)
American Board of
Diplomats in Pharmacy
Council of Deans, AACP
(after 1987, Council of Faculties)
Kentucky Academy of
Science (KAS)
Honor Societies:
Rho Chi, Phi Eta Sigma, Phi Lambda Upsilon, Phi Sigma, Sigma Xi, Omicron
Delta Kappa National Leadership Honor Society.
Professional Pharmacy Fraternity: Kappa Psi
Academic,
Professional and Scientific Awards, Appointments, and Accomplishments:
1939
Elected
after freshman year into membership into Phi Eta Sigma Fraternity, National
Honor Society (at Wisconsin) for good scholarship.
1941
Elected member of Rho Chi, National Honorary Pharmacy Society.
1942 Elected as the first President of the University of
Wisconsin Pharmaceutical Society. This
was the name given to the newly formed student branch of the APhA and the WPhA
at UW-Madison. Graduated with a B.S. in
Pharmacy; and started to study toward a Ph.D. in Pharmacy in September; the
major area of study was in Pharmacy with major Professor Louis W. Busse; the
minor area of study was in Biochemistry with minor Professor Karl P. Link,
discoverer of Warfarin.
1942-43
Began
taking courses in physical pharmacy, mathematics, and other advanced courses in
preparation for a new more highly scientific preparation for graduate research
in pharmacy. Introduced the term
“physical pharmacy” to his newly conceived area of pharmacy education at
Wisconsin, involving learning and applying of physical chemical, mathematical,
and analytical science principles to the teaching and research on drug
compounds and pharmaceutical products; and in studies on the formulating
processing, developing, storing, and evaluating in human subjects of
pharmaceutical dosage forms.
1943-45
Spent
about two years in a Tuberculosis Sanitarium at Statesan, Wisconsin overcoming
a tuberculosis infection in right lung.
Completed by correspondence four college-level semester courses for
credit through UW Extension Services.
These included College Algebra, Analytic Geometry and two courses in
Calculus.
1945-46
Originated
the idea of applying low-temperature nitrogen adsorption technique
(Brunauer-Emmett-Teller Method) to the study of specific surface areas of
pharmaceutical powders; built the (BET Method) equipment at the UW School of
Pharmacy which equipment then was not available commercially; and began the
first physical pharmacy thesis research problem at the University of Wisconsin
(measuring specific surface areas of pharmaceutical powders using
low-temperature nitrogen adsorption technique.)
1942-53
Was
a principal person at the School of Pharmacy at UW in a) conceptualizing and
evolving the discipline of physical pharmacy, and b) bringing his astute
physical-organic-analytical chemist friend (Takeru Higuchi, Ph.D., 1943) from a
job in rubber research in Akron, Ohio to the School of Pharmacy, University of
Wisconsin for a visit in 1946; encouraging him to a) accept in 1947 a faculty
position at UW-Madison in physical pharmacy and b) help him give leadership and
guidance to this newly emerging discipline in pharmacy education. Dr. Higuchi became known across the world of
academic and industrial pharmaceutical sciences for a) original courses he
taught in physical pharmacy, b) the invited lectures he gave, c) presentations
at national and international meetings, d) the great impact he had in bringing
a high level of research in pharmaceutical science to the Schools of Pharmacy
in Wisconsin, and Kansas to which he moved in 1967, e) his 300 or more
published scientific papers in pharmacy, and f) the 100+ graduate students and
post-doctorals for whom he served as major professor during 1948-87. Professor Takeru Higuchi became one of the
top, most prominent, most illustrious pharmaceutical educator-scientists in the
world during the 20th century. He
became especially highly regarded in America where he was born and in Japan from
where his parents immigrated to America.
1948 In August was appointed a full-time Assistant
Professor at Wisconsin. Introduced a
biochemical natural-product perspective to the teaching of pharmacognosy, at the
University of Wisconsin School of Pharmacy.
1948-89 Member of many professional and
scientific pharmacy committees at local, state, national, and international
level.
1948
Was
the senior author (Publications 1, 2, 3) of the first three published physical
pharmacy research papers (using BET Method) to emerge from the University of
Wisconsin; and helped to give international visibility to the start-up of
teaching and research in physical pharmacy.
1953
Took
one-year leave of absence from UW School of Pharmacy to obtain experience in
industrial pharmaceutical R&D; however in reality it lasted for about 14
years.
1953
Joined
Smith Kline & French Laboratories (SK&F), Philadelphia,
Pennsylvania. Was one of the first
Ph.D. graduates in pharmaceutics (rather than pharmaceutical chemistry)
to join a pharmacy R&D section in pharmaceutical industry. Was the first person with a Ph.D. in
Pharmacy (Pharmaceutics) in R&D at SK&F. Was asked to direct much attention to formulation theory and
practice, applicable to making and marketing oral sustained release products,
then a budding new product area.
Introduced for the first time hydrogenated castor
oil and ethylcellulose as useful agents for coating pellets and for effecting
oral sustained release from coated drug pellets, from embedded granules and
from tablets. These agents are now
widely used for such purpose.
Reported to SK&F scientific leaders in 1953 his
observations of first-order elimination rate in humans of drugs including
theophylline, penicillin G, sulfas, etc., for which he published in JAPhA, Sci.
Ed. their biologic half-lives for the first time ever (Pub. 17). He revealed the importance of biologic
half-life and first-order drug elimination rate in rational design of dosage
forms and regimens and their evaluations in human subjects; with applications
especially to controlled drug release products. His public presentations (1955-56) and publications regarding
biologic half-lives of well known drugs revolutionized the teaching of duration
of action of drugs in pharmacy, medical and other health care schools (Pubs 17,
18, 19). He helped to establish the
concept of drug bioavailability from oral sustained release dosage forms, and
evolved methods and began publishing papers later; especially reporting upon
the bioavailability of drugs from oral sustained release and also
enteric-coated products. These new
evaluation methods are illustrated in (Pubs 25, 33).
1953-87
Referee
for journal articles especially Journal of Pharmaceutical Sciences.
1954-70
Invented
and developed the double-layered oral sustained release tablet, and later
received a patent for it, along with numerous other patents.
1955-56
Invited
AACP lecturer on “Illustrations and Pharmaceutical Interpretation of
First-Order Drug Elimination Rate From the Bloodstream” and the importance of
such kinetic concepts to drug product development and use. Lectures given at Colleges of Pharmacy at
Purdue, Florida A&M, and South Carolina.
Paper with the above title was published in 1956, and was runner-up for
APhA Ebert Prize in 1957.
1957 Fellow, American Association for
Advancement of Science (AAAS).
1958
National
Ebert Prize (for Pubs 20, 21 in American Pharmaceutical Association) for
introducing a) the biologic half-life (t ½) concept to teaching, research and
pharmacy patient care services in American pharmacy, b) t½ applications to
rational dosage form design using sulfaethylthiadiazole as the drug for study,
and c) the use of physical pharmacy concepts in in vivo study aspects of
drug absorption-distribution-metabolism-excretion, product development, and
clinical drug product evaluation. He
initiated in 1954 the earliest reported biopharmaceutical and human
pharmacokinetic studies emerging from an industrial pharmacy product
development group; and the public scientific lectures he gave in 1955 with the
published reports starting in 1956, of his data and methods, changed profoundly
the directions of academic and industrial pharmaceutics studies. They changed from only traditional in
vitro pharmaceutics studies to include much more encompassing physical
pharmacy in vivo studies involving physical pharmacy, preformulation
studies, biopharmacy, and clinical pharmacokinetic development studies in
pharmaceutical R&D. (Pubs 22, 25, 27, 28, 29, 30, 36, 37, 55, 105)
Introduced at SK&F the prodrug concept into
search for new patentable and marketable therapeutic agents, getting several
patents for new drugs. (Patents 2-10).
1958-67
Adjunct
Professor, Temple University School of Pharmacy in addition to full-time
employment at SK&F.
1960-61
Vice-President
of the American Association for the Advancement of Science (AAAS), and Chairman
AAAS Pharmacy Section.
1961
George
Beecher Kauffman Lecturer, Ohio State University.
University Honorary
Citation, University of Wisconsin.
1961-62
President,
American Pharmaceutical Association (APhA), Philadelphia branch.
1963-67
Visiting
Scientist across the country of the American Association of Colleges of
Pharmacy (AACP).
1963 National, Pharmacy Achievement Award of the American
Pharmaceutical Association (APhA).
Pharmacy Achievement Award of the American
Pharmaceutical Association (APhA), Philadelphia branch.
1964
National,
American Pharmaceutical Association (APhA) Foundation Award in Physical
Pharmacy.
Honorary Member, University of Wisconsin School of
Pharmacy Alumni Association.
Gave a major opening address; invited scientific
paper on Drug absorption at meeting of Japanese Pharmaceutical Society, Tokyo,
April.
1964-65
Chairman,
Scientific Section of the American Pharmaceutical Association (APhA).
1964-69
Editorial
Advisory Board, Journal of Pharmaceutical Sciences.
1965-67
Vice-President,
Rho Chi National Honorary Society.
1965-69
Executive Committee Member, and a principal founder of the Academy
of
Pharmaceutical
Sciences of the APhA.
1965 Initiated and evolved the concept at SK&F of an
experimental in situ rat gut
technique for studying factors effecting rates and amounts of drug absorption
from a gut in which the vascular system was intact. The technique was perfected at Kentucky during 1967-68 with
research colleagues. First-order rate
kinetics of drug absorption was frequently observed and the data
published. This experimental method and
variations of it has had considerable use in many laboratories in America and
abroad.
1966
Kremers
Memorial Lecturer, University of Wisconsin, School of Pharmacy.
Invited scientific paper on Prodrugs, Polish
Pharmaceutical Society, Lublin, Poland.
1967
Became
Dean, effective January 1, University of Kentucky College of Pharmacy. Made some major additions to the College
faculty of some very creative and productive young faculty people. Initiated patient care oriented pharmacy
education at Kentucky and also in America, through major curriculum overhaul
and by obtaining administrative sanction to a) use the University of Kentucky
Hospital for attaining objectives of integrated clinical teaching, research,
and services in pharmacy, and b) having the Director of Pharmacy Central
Supply of the University Hospital report administratively to the Dean of the
College of Pharmacy. The above actions
had a profound effect on how professional pharmacy education in America would
evolve, leading ultimately to the universal patient care oriented Pharm.D. as
the entry degree for the practice of pharmacy in America.
1967-68
Opened
the gates to experiential education for college credit by getting authorization
from Medical Center Administration to use hospital and community pharmacy
settings, establishing voluntary faculty titles and responsibilities for
pharmacy practitioners in our College teaching, service and research programs. Brought a strong patient health care and
scientific emphasis to pharmacy teaching and research programs; provided a
precedent and model for other colleges of pharmacy to follow which helped to
influence other colleges of pharmacy in America (and a few abroad) to adopt a model
for pharmacy patient health care education.
This has resulted in pharmacists being educated to be the authorities on
the appropriate, safe, and effective use of drug products; and enabled them to
become active participants on the health care provider teams in patient care;
and in monitoring patient use of drug products, and in evaluating therapeutic
outcomes. Helped to pioneer computer
use in maintaining drug patient care records.
President, (APhA) Academy of
Pharmaceutical Sciences (APS).
1967
Elected
Active Member, New York Academy of Sciences.
1968 Pharmaceutical Research Discussion Group in New
Jersey-New York area gave Best Paper Award for 1968, of paper appearing in
Journal of Pharmaceutical Sciences in 1967.
Took steps to give administrative order and bring
high morale to the UK College of Pharmacy family; and set the stage for change,
rapid academic achievement, and progress.
Adopted some aspects of industrial administrative techniques to the
academic setting. Established for the
UK College of Pharmacy, a) organization, including a committee structure, b)
plans and goals for the college family and expectations for progress, c) job
descriptions for faculty d) annual performance evaluation procedures, e) annual
synopsis of faculty member’s work load, distribution of effort, and
accomplishments in teaching, research, and professional and public service, f)
newsletter, The Spatula, as a public information and public relations
instrument for maintaining college contact with students, faculty, staff,
alumni, Kentucky pharmacists, and friends, g) policies for time away from the
college, meeting attendance, consulting, and vacation, h) established a College
committee system stating the goals and responsibilities of each committee and
its Chairman, annual accountability in writing, new annual goals of the
Committee in writing, along with oral reports from the Committees at faculty
meetings, and i) an annual report of the College of Pharmacy for higher
University administration, and an abbreviated annual report for publication in
the Kentucky Pharmacist (journal).
These were major administrative accomplishments benefiting especially
the personal and collective development of pharmacy faculty at a time when such
administrative approaches were not commonplace in academia, and when written
annual reporting and accountability were unheard of at UK Colleges.
Established at the College in 1968 a Ph.D. research
program, an optional Pharm.D. professional program and a residency program
managed and conferred by the College, but with strong inputs from the
University Hospital and practice sites.
Became registered pharmacist by examination through
Kentucky State Board of Pharmacy.
Recommended establishment of the Annual Higuchi
Research Seminar, which then became a reality for the University of Kansas
College of Pharmacy where Takeru Higuchi maintained a professorial appointment
from 1967 until his death in 1987.
Encouraged and attracted the first postdoctoral
academicians from a pharmacy university (Kumamoto) in Japan to spend a
year in Kentucky with us to study drug absorption. Over the years many Ph.D.s from Japan followed this path.
1970 Fellow, Academy of Pharmaceutical Sciences of the
American Pharmaceutical Association.
Honorary Member, Polish
Pharmaceutical Society.
1970-85
Appointed
Member, United States Adopted Names Review Board (USAN Review Board).
1971
Invited
to give scientific paper on the kinetics of
absorption-distribution-metabolism-excretion of sulfaethylthiadiazole at
Foresta Hotel Medical Seminar, Stockholm, Sweden, March.
Was a pioneer in promoting clinical education in
pharmacy. Invited to present
professional and educational paper on Clinical Pharmacy Education sponsored by
AACP-ASHP Clinical Pharmacy Conference, Kansas City, Missouri.
Lecture on Trends in Pharmacy Education, College of
Pharmacy, Poznan, Poland, March.
Lecture on Trends in Pharmacy Education, College of
Pharmacy, University of Ljubljana, Yugoslavia, April.
Discussion Leader, National Industrial
Pharmaceutical Research Conference, Land O’ Lakes, Wisconsin, June.
1972
Duke
of Paducah Award, City of Paducah, Kentucky.
Discussion Leader, Higuchi Research Seminar, Lake
Ozark, Missouri, March.
Lecturer, Seminar on Clinical Education and
Practice, College of Pharmacy, North Dakota State University, Fargo, ND, March.
Participant, Advisory Panel for Merck, Sharp and
Dohme concerning needs of pharmaceutical education today, North Wales, PA,
June.
Member, Section for General Practice of Pharmacy,
Working Group 3, International Pharmaceutical Federation, Lisbon, Portugal,
September. Elected Secretary of Working
Group 3.
1972-74
Appointed
member, Kentucky Drug Formulary Council, State of Kentucky, focusing in on how
to get a broader use of generic (and cheaper) drug products in Kentucky.
1974 UK Alumni Association Award (for the College) for
being selected by pharmacy deans across the country as one of the best colleges
(4th) among all colleges of pharmacy in America.
Speaker for the investiture of Dr. William Owen Foye
at Massachusetts College of Pharmacy as Sawyer Professor of Pharmaceutical
Sciences; and Commencement Address speaker to Massachusetts College of Pharmacy
students on same occasion.
1975
National
Industrial Pharmaceutical Technology Award, San Francisco, CA, April, sponsored
by APhA.
1975
USA
Steering Committee Member, General Practice Section, FIP.
1976
Participant,
International Symposium on Bioactivation and Controlled Drug Release,
Stockholm, Sweden, April.
Invited scientific paper on Biopharmacy, Theory and
Practice, Budapest, Hungary, September, and at Hungarian Pharmaceutical
Association Meeting.
Participant, and Secretary of Working Group 3,
General Practice of Pharmacy Section, International Pharmaceutical Federation
(FIP), Warsaw, Poland, September.
1976-77
Member,
Nominations Committee, Academy of Pharmaceutical Sciences.
1976-80
Member,
VA Health Manpower Grants Review Committee.
1976-84
Member,
The American Board of Diplomats in Pharmacy – International.
1976-85
U.S.
Coordinator, Academic Section, International Pharmaceutical Federation (FIP).
Consultant, International Consultant, Inc. Advisory
Council Committee.
1977
Invited
Lecturer on Progress in Pharmaceutical Education to Jordan Pharmaceutical
Society, Amman, Jordan, February.
Participant, presented three lectures, Pharmacy
Postgraduate Course, Ministry of Health, Kuwait, February.
Invited presentation at National Health Insurance
Hearing sponsored by HEW, Lexington, Kentucky, October.
Honorary Member, Association of Pharmacy Teachers in
India (APTI Council).
1978-80
Member,
Editorial Board, RPh Journal.
1978-85
Member,
Selections Committee for Honorary Membership in Academy of Pharmaceutical
Sciences.
1979
Invited
paper on safety in medicine, FIP meeting, Brighton, England, “Inclusion of
Safety Testing on Drugs in the Pharmacy Syllabus: Chemical and Pharmaceutical Aspects,” September.
1979-87
Member,
Kentucky Pharmacists Association Legislative Committee.
1980
Appointed,
University/Health Science Advisory Committee, UK.
1980-87
Appointed
Member, Tobacco and Health Administrative Advisory Committee, University of
Kentucky (UK).
1981
Invited
presentation of the paper entitled, “Origination and Application of the In
Situ Rat Gut Technique. A Way of
Using It for Evaluating the Effect of Adjuvants on Drug Absorption” in colleges of Pharmacy in Gdansk, Poznan,
and Warsaw, Poland, September; also at FIP Meeting, Vienna, Austria.
1981-83
Member,
Time and Place Committee, District 4 NABP-AACP.
1982
Moderator
of Session on Drug Product Quality Control, 2nd Drug Symposium at
King Saud University College of Pharmacy, Riyadh, Saudi Arabia, March.
Invited presentation of paper entitled, “Personal
Experiences in the Early Days of Biopharmacy and Pharmacokinetics,” Sidney
Riegelman Memorial Symposium, San Francisco, CA, April.
Invited presentation, “The need of Pharmaceutical
Education in Kuwait,” The First Kuwait Conference of Pharmaceutical Sciences,
Safat, Kuwait, November.
Chairman, APhA Academy of Pharmaceutical Sciences
Committee on Honorary Members, 1982-83.
Member, Kentucky Pharmacists Association Continuing
Education Advisory Committee, 1982-83.
1983
Invited
presentation, “Prodrugs and the Potential of
SKF 26070,” Smith Kline & Bechman Laboratories, Philadelphia, PA,
May.
Host and Delegation Leader for professional
delegation of pharmacists and pharmaceutical and biomedical scientists to USSR
and The People’s Republic of China. The
delegation, organized by People-To-People, July 2-23.
Participant, FIP Meeting in Montreaux, Switzerland
during September 3-9; also presented lecture on “Directions of Pharmaceutical
Education” (at college of pharmacy at the University of Ljubljana, Yugoslavia).
Initiated construction planning for a new UK College
of Pharmacy building that had been promised, but postponed from when it was
first promised in 1967 by University and Medical Center Administration.
Panelist, University of Wisconsin Centennial
Symposium, Madison, Wisconsin, October 2-4, “Education of the Pharmaceutical
Scientist; Needs of Schools of Pharmacy”.
1984
National
Rho Chi Lecture Award, Montreal, Quebec, Canada.
1984-87
Elected
Member, Electorate (Pharmaceutical Sciences) Nominating Committee, American
Association for Advancement of Science.
1985
Member,
Kentucky Academy of Science.
Invited Presentation of paper on pioneering effort
on our “An Off-Campus
Post-Baccalaureate Professional Doctoral Teaching Program”, FIP Meeting,
Montreal, Canada, September.
1986
Invited
Participant, Symposium, “Educating Health Care Professionals; The Next
Twenty-Five Years”, Lexington, Kentucky, April.
Acquisition of new Pharmacy Building in fiscal
1985-86. Address at Dedication
Ceremonies, May.
Lecturer at Universities and Colleges of Pharmacy in
Poland, “A Vision of Pharmacy and Pharmaceutical Education for the
Future’. Received Honorary Doctorate
degree from Poznan Medical Academy, September.
Lecturer, “Research in Colleges of Pharmacy” Charles
University Pharmacy School, Hradec Kralove, Czechoslovakia, September.
Invited Lecturer and gave three presentations at the
University of Ljubljana, Ljubljana, Yugoslavia, September; Titles of papers
given in Poland, Czechoslovakia and Yugoslavia were: “Vision of Pharmacy and Pharmacy Education for the Future”, “How
A Clinically Oriented Curriculum was Evolved in Pharmacy Education at Kentucky
and Its Value to Pharmacy”, and “Recent Trends in Pharmaceutical Research and
Development – Programs Within the UK College of Pharmacy”, September.
Presented paper, “A Statement Opposing Specialty
Status for (the name) Clinical Pharmacy; And in Support of a Curriculum With a
Strong Patient Care Oriented Emphasis for Meeting the Requirements for the
General Practice of Pharmacy”, at the American Society of Hospital Pharmacists
Midyear Clinical Meeting, Las Vegas, Nevada, December.
Initiated into membership of Omicron Delta Kappa,
National Leadership Honor Society.
Distinguished Service Award, Kentucky Pharmacists
Association.
Charter member and one of the founders of American
Association of Pharmaceutical Scientists (AAPS).
1987
Japan
Society for the Promotion of Science, Fellowship for Research, April 1-15, and
invited speaker at several universities and industries in Japan.
Presented invited paper, Japanese Pharmaceutical
Society (JPS) Meeting, Kyoto, Japan, entitled, *”Pharmacy and Pharmaceutical
Education: Future Change and Growth,” April 3, 1987.
Presented lecture, Academy of Pharmaceutical Science
and Technology of Japan (APSTS), Hoshi University, Tokyo, Japan, April,
entitled, **”A Lifetime of Personal Experiences in Pharmaceutical Education and
Science and Their Influences On Pharmacy and Pharmacy Education”, April.
Invited lecture, Sankyo Co., Tokyo, Japan,
April. “Pharmacy and Pharmaceutical
Education: Future Changes and Growth”.
*** Invited Lecture, “Development of Clinical
Education at Kentucky”, Kitasato University, Tokyo, Japan, April. Also, gave same paper as one given at Hoshi
University, Tokyo**.
Invited lectures at China Pharmaceutical University,
Nanjing, China. Same titles as three
lectures given in Japan during April, 1987.
Invited lectures, College of Pharmacy, West China
Medical University, Chengdu, China, titles as given in Japan, April, 1987.
Fellow, American Association of Pharmaceutical
Scientists, June.
The Merck Sharp & Dohme Award for Outstanding
Achievement in Profession of Pharmacy, June.
Blue Grass Pharmacists Association Award for
Distinguished Service to Pharmacy and the Community.
1987 Distinguished Alumnus Award, University of
Wisconsin Alumni Association.
Received Distinguished Scientist Award for 1987
from the Kentucky Academy of Science, November.
1988 Dean Joseph B. Sprowls Lecture
Award, Temple University, September.
Chairman, Fellows Selection Committee of AAPS.
1989 Received the Host-Madsen Medal Award of the
International Pharmaceutical Federation (FIP) at the Munich Meeting in
September, 1989. In an international
competition, the award is given by the FIP Board of Pharmaceutical Sciences to
a pharmacist whose work in pharmaceutical sciences has been distinguished. In 1989 Dr. Swintosky was only the third
American pharmaceutical scientist to receive this gold medal award.
1990
Received
the Volwiler Research Achievement Award Medal at AACP Meeting in Las Vegas,
Nevada, September 10, 1990. Gave
Volwiler Award Lecture at this meeting.
Also gave lecture at Abbott Laboratories who sponsors the award, on
September 28, 1990.
1991
Received
the 1991 American Foundation for Pharmaceutical Education (AFPE) Former Fellow
Distinguished Service Profile Award at the January 24, 1991, AFPE Board meeting
in New York City. This award is given
to honor Former Fellows who have made outstanding contributions to pharmacy
during their career.
Received the Distinguished Kentuckian in Pharmacy
Award on April 24, 1991 at a dinner held at the Hiliary Boone Faculty Club,
Lexington, Kentucky. The nomination for
this award came from the University of Kentucky College of Pharmacy faculty.
1992
Invited
contributor to series of published books comprising a Memorial Tribute of which
my chapter was entitled, “Takeru Higuchi, Esteemed Pharmaceutical Scientist”.
1993
Invited
Presentation, “How and Why the University of Kentucky College of Pharmacy Took
A Primary Leadership Role in The Drive Toward Patient Care Oriented Pharmacy,
Teaching, Research, and Professional Services”, Kitasato-Kentucky Joint
Clinical Pharmacy Symposium, Kitasato University, Tokyo, Japan, September 3,
1993.
1994
Endowed
Lecture Series, Dr. Joseph V. Swintosky Distinguished Lecture Series
established at the University of Kentucky College of Pharmacy in honor of
Emeritus Dean Joseph V. Swintosky.
1983-99 Persuaded and encouraged Dr. Eunice
Bonow Bardell to write the “History of our UK College of Pharmacy Covering the
Period of 1970-85”. Publication of a
book on this subject with Dr. Bardell as author occurred in 1999.
Editorial
Activity
1964-69
Editorial
Advisory Board, Journal of Pharmaceutical Sciences.
1978-80
Editorial
Board Member, RPh Journal.
1957-87
Reviewer,
American Journal of Pharmaceutical Education, and Journal of Pharmaceutical
Sciences.
Research
and Other Academic Interests
1.
Curriculum
development. Standards of education in
pharmacy.
2.
Pharmacist
professional development, and ethics in pharmacy.
3.
Administration
in pharmaceutical industry and education.
4.
Developing
new roles for pharmacists.
5.
Pharmaceutics,
biopharmaceutics, and pharmacokinetics.
6.
Drug
product design – development – stabilization – evaluation. Concepts and suggestions for new products.
7.
The
processes of pharmaceutical technology and formulation.
8.
Sustained
and controlled drug absorption, distribution, metabolism, and excretion.
9.
Making
and evaluating new prodrugs.
10.
Drugs
from living sources.
11.
Developing
technology for controlled release of drugs from oral dosage forms.
Patents
10 distinct U.S. pharmaceutical patents, each listed
in several countries, for a total of about 40.
Publications
Approximately 130 scientific and educational
articles (including 10 U.S. patents).
Pastimes
Gardening, picnicing, fishing, spectator at
baseball-basketball-softball-football games where sons and grandchildren
participate, sports generally, traveling, and spending leisure time with
family; compiling and studying family genealogy, and playing card game called
schafskopf (sheep head).
Click here to view
publications